Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

According to the currently available data from large cohort studies, patients with immuno-inflammatory rheumatic diseases (IIRDs) are at increased risk of infectious complications, including influenza, compared to the general population. Vaccinations are a critical component of their care. However,...

Полное описание

Библиографические подробности
Главные авторы:	M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. E. Diatroptov, D. V. Bukhanova
Формат:	Статья
Язык:	Russian
Опубликовано:	LLC "Publishing House OKI" 2024-06-01
Серии:	Антибиотики и Химиотерапия
Предметы:	influenza rheumatoid arthritis ankylosing spondylitis psoriatic arthritis vaccination efficacy immunogenicity safety
Online-ссылка:	https://www.antibiotics-chemotherapy.ru/jour/article/view/1129

Схожие документы

Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis
по: M. M. Baranova, и др.
Опубликовано: (2024-06-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
по: D. V. Bukhanova, и др.
Опубликовано: (2018-07-01)

Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
по: Alyssa Howren, и др.
Опубликовано: (2025-01-01)

Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta‐analysis
по: Matthew Carroll, и др.
Опубликовано: (2015-01-01)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
по: Svedbom A, и др.
Опубликовано: (2017-01-01)

Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study
по: Zlatković-Švenda Mirjana, и др.
Опубликовано: (2022-01-01)

Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases
по: Hermine Leroi, и др.
Опубликовано: (2020-05-01)

Comorbidities in inflammatory joint and spine diseases in XXI century
по: I Z Gaydukova, и др.
Опубликовано: (2018-12-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
по: Takacs P, и др.
Опубликовано: (2019-01-01)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
по: Joshua L. Lee, и др.
Опубликовано: (2018-08-01)

The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
по: M. M. Baranova, и др.
Опубликовано: (2021-03-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
по: M. Rossini, и др.
Опубликовано: (2015-03-01)

Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics
по: Taras S. Panevin, и др.
Опубликовано: (2024-06-01)

The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis
по: I. Pantano, и др.
Опубликовано: (2023-03-01)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
по: Milena Iwaszko, и др.
Опубликовано: (2021-11-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
по: Viola Sacchi, и др.
Опубликовано: (2010-06-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
по: Krzysztof Bonek, и др.
Опубликовано: (2022-04-01)

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis
по: Santhi Mantravadi, и др.
Опубликовано: (2020-09-01)

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
по: Philip Brenner, и др.
Опубликовано: (2020-02-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
по: E. E. Gubar, и др.
Опубликовано: (2023-08-01)

Nod-like receptors in inflammatory arthritis
по: Sahib Singh Madahar, и др.
Опубликовано: (2024-02-01)

Inflammatory arthritis and eye diseases: a Mendelian randomization study
по: Xinlin Nie, и др.
Опубликовано: (2023-10-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
по: M. Elaine Husni, и др.
Опубликовано: (2022-03-01)

A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study
по: Christian Dejaco, и др.
Опубликовано: (2022-06-01)

SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS
по: D. V. Bukhanova, и др.
Опубликовано: (2018-07-01)

The association of relapsing polychondritis and spondylarthritis – three case reports
по: Eleonora Alina Dragomir-Lica, и др.
Опубликовано: (2023-09-01)

Characteristics of patients with psoriatic arthritis in Korea: focusing on axial involvement
по: Hanna Park, и др.
Опубликовано: (2024-01-01)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
по: Acar M, и др.
Опубликовано: (2018-11-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
по: Yu. V. Muravyev, и др.
Опубликовано: (2020-05-01)

Adherence to biological therapies in patients with chronic inflammatory arthropathies
по: Noemí Martínez-López de Castro, и др.
Опубликовано: (2019-07-01)

Unraveling immune cell heterogeneity in autoimmune arthritis: insights from single-cell RNA sequencing
по: Sotaro Nakajima, и др.
Опубликовано: (2024-10-01)

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
по: Andrea Picchianti-Diamanti, и др.
Опубликовано: (2025-02-01)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
по: Giovanni Cioffi, и др.
Опубликовано: (2021-03-01)

Diagnosis of spondyloarthritis: should we need new criteria?
по: I. Z. Gaidukova, и др.
Опубликовано: (2015-03-01)

Prevalence of spondyloarthritis and its subtypes - are they really comparable?
по: Zlatković-Švenda Mirjana I., и др.
Опубликовано: (2019-01-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
по: R. M. Balabanova, и др.
Опубликовано: (2021-06-01)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
по: Muhammad Haroon, и др.
Опубликовано: (2018-04-01)

Newly diagnosed seropositive rheumatoid arthritis in a 52-year-old man superimposed on long-standing ankylosing spondylitis during secukinumab treatment
по: Jaroslaw Nowakowski, и др.
Опубликовано: (2023-10-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
по: Tacjana Anna Barczyńska, и др.
Опубликовано: (2015-12-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
по: T. V. Dubinina, и др.
Опубликовано: (2023-02-01)